The press releases contained in this archive section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. Nicox disavows any obligation to update the information contained in such press releases after the date of their issuance.
08 September 2017Read moreDetails
Nicox announces the issuing and admission to trading on the Euronext regulated market in Paris of 597,897 new shares awarded to former Aciex shareholders following the US FDA’s approval of the new drug application in the US for ZERVIATE (cetirizine ophthalmic solution) 0.24%.
08 June 2017Read moreDetails
22 September 2016Read moreDetails
16 September 2014Read moreDetails
21 March 2012
Nicox S.A. (NYSE Euronext Paris: COX) today announces that its Board of directors has unanimously decided at its May 31, 2012 meeting not to exercise NicOx’s option to acquire the remaining 88.2% of equity of Altacor. Nicox acquired 11.8% of the equity of Altacor in March 2012. Accordingly, the option to acquire the remaining shares of Altacor lapsed on May 31,Read moreDetails
15 September 2010Read moreDetails
15 September 2005Read moreDetails